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A B S T R A C T
A cost-effective alternative approach capable of determining the prevalence of substance use in communities can
complement the existing efforts of combating drug abuse and addiction. In this study, the prevalence of 10 illicit
and 19 prescribed psychoactive drugs of potential abuse was determined utilizing wastewater-based epide-
miology, and compared in two adjoined urban communities and a rural community. This is the first application
of the Monte Carlo simulation method to account multiple uncertainties and propagation of errors associated
with the individual parameter of wastewater based epidemiological estimations in the U.S. A significantly higher
prevalence of cocaine [3830 (mean difference, MD: 2960) mg/d/1000 people] was found in the central business
district while the per-capita consumption rates of amphetamine [738 (MD: 338) mg/d/1000 people] and me-
thamphetamine [1660 (MD: 629) mg/d/1000 people] were higher in a rural community. Among narcotics, the
per-capita consumption rate of fentanyl and morphine was significantly higher in urban communities while
codeine, hydrocodone, hydromorphone, and buprenorphine were dominant in a rural community. The sig-
nificantly higher prevalence of buprenorphine (˜20-30 folds), oxycodone (˜2-3 folds), and alprazolam (˜2-3 folds)
determined in these communities compared to the conventional estimates based on the electronically reported
prescriptions and drug-related inpatient hospitalizations suggest the abuse of these drugs.
https://doi.org/10.1016/j.jhazmat.2019.121306
Received 22 May 2019; Received in revised form 5 September 2019; Accepted 23 September 2019
⁎ Corresponding author at: Department of Chemistry, Murray State University, 1201 Jesse D. Jones Hall, Murray, KY 42071, United States.
E-mail address: bsubedi@murraystate.edu (B. Subedi).
Journal of Hazardous Materials 384 (2020) 121306
Available online 24 September 2019
0304-3894/ © 2019 Elsevier B.V. All rights reserved.
T
1. Introduction
The prevalence of substance uses and addiction is growing as a
global threat to social and economic well-being (United Nation Office
on Drugs and Crime, 2018). In the U.S., the ongoing opioid epidemic
was declared in 2017 as a national public health emergency, while
other drugs of abuse remain prevalent (U. S. Department of Health and
Human Services, 2019). For the first time in half a century, the life
expectancy in the U.S. has declined in 2015 and 2016 with a key factor
being a rise in drug-related deaths. Therefore, the timely, cost-effective,
and comprehensive measure of the prevalence of substance use has
never been more imperative before.
Wastewater-based epidemiology (WBE) is a fast-growing approach
for the estimation of consumption of a chemical substance in the
community as complementary to the conventional survey-based ap-
proaches (Foppe et al., 2018; O’Brien et al., 2019). WBE has been
exploited to estimate the consumption statistics of the illicit drugs
(European Monitoring Center for Drugs and Drug Addiction (EMCDDA),
2019; Australian Criminal Intelligence Commission (ACIC), 2019;
Subedi and Kannan, 2014; Burgard et al., 2019), potentially abused
prescribed drugs (Subedi et al., 2015; Skees et al., 2018), as well as
evaluate the human exposure to the classic persistent pollutants such as
pesticides (Rousis et al., 2017), emerging pollutants such as flame re-
tardants (Been et al., 2018) and phthalates (González-Mariño et al.,
2017; Du et al., 2018), and several other public health biomarkers such
as diet (Venkatesan et al., 2019), pathogenic bacteria (Fernandez-Cassi
et al., 2018), and virus (Prado et al., 2012). In WBE, the trace level of
drug biomarkers in raw wastewater is used to back-calculate the com-
munity consumption of drugs which can reveal the trend of drug con-
sumption (Mastroianni et al., 2017) and the effectiveness of the au-
thorities’ efforts to combat drug abuse (Li et al., 2019; Been et al.,
2016a).
Conventionally, the prevalence of substance use has been estimated
based on a combination of toxicology reports, crime statistics, and self-
reported survey questionnaires. The conventional approaches suffer
from the high cost, limited coverage, time delays for the prompt need of
intervention, and biases including nonresponse bias and bias in the
selection of sample population with the higher use of drugs (Keshaviah
et al., 2016); therefore, potentially underestimate the actual con-
sumption of drugs. WBE is a comprehensive, cost-effective, and near-
real-time approach that can be used as an early warning system for the
prevalence of substance use or public health. However, there are sev-
eral methodological uncertainties associated with the WBE: analytical
uncertainties such as the selection of sampling period, sampling
method, storage, sample pre-treatment, extraction, and quantification
as well as the uncertainties corresponding to the parameters that are
considered for back-calculation such as wastewater inflow, stability of
drugs in wastewater, pharmacokinetics of the biomarker, and the po-
pulation served by the wastewater treatment plant (WWTP) (Subedi,
2019; Castiglioni et al., 2013).
The stability kinetics of a drug in wastewater depends on the
complexity of wastewater matrix, the residence time, temperature, and
pH (Subedi, 2019). There is a wide-range of stability of drugs reported
at varied experimental conditions such as the time period (12 h, 24 h,
72 h, etc.), temperature (-20 °C to 20 °C), pH (1.8–7.5), and spiking
levels of drugs (60–1000 ng/L) (Table S1) (van Nuijs et al., 2012; Baker
and Kasprzyk-Hordern, 2011). Similarly, the pharmacokinetics depends
on the routes of drug administration, habits of consumption, dose
amount, duration of drug administration, and individuals’ metabolism
(Table S2) (Khan and Nicell, 2011). For instance, the estimated national
prevalence of cocaine consumption based on an average rate of excre-
tion was underestimated by 29% when considering nasal insufflation
and by 182% when considering smoking as a primary mode of con-
sumption compared to an estimate based on the constructed excretion
profile of cocaine incorporating all potential routes of administration
(nasal, insufflation, smoking, injection, and oral ingestion).
The conventional population estimates such as a round-figure po-
pulation provided by the WWTP personnel and a census-based estimate
does not account for the population dynamics such as population
growth, day-specific variability, day–night variability, and residents’
use of septic systems or straight-piping (Subedi, 2019). Therefore, de
jure population introduces one of the greatest uncertainties for WBE
estimation and consequently under- or overestimate the actual con-
sumption (Been et al., 2014). The population dynamicity within WWTP
catchment has been typically estimated based on the hydrochemical
parameters (van Nuijs et al., 2011; Zheng et al., 2019), Bayesian In-
ference model incorporating the mass loads of chemical marker in
census day (O’Brien et al., 2014), endogenous or exogenous biomarkers
such as creatinine and 5-hydroxyindoleacetic acid (Brewer et al., 2012),
and geographical and time reference mobile call information (Thomas
et al. (2017)). Ammonia, a product of hydrolysis of urea, is a relatively
more selective human-derived biomarker in wastewater - used to de-
termine a near-accurate population in WWTP catchments and examine
the diurnal variation in the prevalence of substance abuse in Switzer-
land (Been et al., 2014) as well as the trend in consumption of tobacco
(Zheng et al., 2017) and methamphetamine in China (Zheng et al.,
2019). There are very few studies that reported a statistical range of
consumption rates incorporating the associated uncertainties. For in-
stance, Been et al. determined the consumption rates of three opioids
addressing uncertainties associated with flow measurements, chemical
analysis, excretion, and adsorption of target drugs onto the suspended
particulates using Monte Carlo simulation (Been et al., 2016b). The
computational algorithm on WBE findings provided the close-agree-
ment to the estimated load of morphine based on prescriptions and
sales data in Switzerland as well as the methamphetamine prevalence in
China compared to the official report (Zheng et al., 2019). Lai et al.
(2011) also propagated the individual uncertainties associated with
sampling, chemical analysis, flow measurements, excretion rates, and
population in the WWTP catchments (Lai et al., 2011).
Despite being considered one of the countries with the highest
prevalence of substance use, there are very few WBE studies reported in
the U.S. (Gushgari et al., 2018). To the authors’ knowledge, this is the
first study utilizing Monte Carlo simulation to incorporate the un-
certainties associated with the wastewater-based epidemiological de-
termination of the prevalence of substance use in two relatively large
(> 150,000 population) urban and a rural (˜20, 000 population) com-
munities in the U.S. The major objectives of this study were to (i) ac-
count for the uncertainties associated with the WBE using Monte Carlo
simulation, (ii) determine the prevalence of ten illicit drugs [cocaine,
amphetamine, methamphetamine, heroin, morphine, methadone, 3,4-
methylenedioxymethamphetamine (MDMA), 3,4-methylenediox-
yethylamphetamine (MDEA), 3,4-methylenedioxyamphetamine (MDA),
and Δ9-tetrahydrocannabinol (THC)] and nineteen neuropsychiatric
drugs (methylphenidate, codeine, fentanyl, oxycodone, hydrocodone,
hydromorphone, buprenorphine, quetiapine, aripiprazole, lorazepam,
alprazolam, diazepam, oxazepam, temazepam, carbamazepine, sertra-
line, fluoxetine, venlafaxine, and citalopram) in urban communities,
(iii) compare the prevalence of substance uses between two adjoined
urban communities and that with a rural community, and (iv) compare
the WBE-derived prevalence of substance uses with the conventional
estimates. Moreover, the potential of three hydrochemical markers in
raw wastewater was evaluated to determine a near-real population
served by the WWTP.
2. Materials and methods
2.1. Sample collection and preparation
Two WWTPs from two adjoined urban communities in eastern
Kentucky were sampled for seven consecutive days during a typical
week in late summer of 2018. Twenty-four-hour composite samples of
raw wastewater (one aliquot every 15min) were collected using a time-
T.L. Croft, et al. Journal of Hazardous Materials 384 (2020) 121306
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proportional autosampler and maintained at 4 °C during the collection
period. According to the WWTP facility operators, WWTPA serves a
population of ˜190,000 people (60% of the city) and treats an average
of 27.2 million gallons per day (MGD) of sewage from industrial and
metropolitan areas. WWTPB serves a population of ˜150,000 people and
treats an average of 21 MGD of sewage from more suburban areas. All
collected samples were transported on ice to the laboratory and ex-
tracted within six hours of collection.
The detailed sample preparation procedures are described else-
where (Foppe et al., 2018; Skees et al., 2018). Briefly, the collected
samples were allowed to equilibrate to room temperature, thoroughly
mixed, centrifuged 100mL of wastewater at 4500 rpm for 5min, and
vacuum filtrated using glass fiber filter paper (1.2 μm, 4.25 cm dia-
meter) to separate suspended particulate matter (SPM). Filtered sam-
ples were spiked with internal standards mixture (containing 50–150 ng
of each analyte) and extracted using Oasis® hydrophilic-lipophilic bal-
ance (HLB) solid phase extraction (SPE) cartridges. Cartridges were
conditioned with 3mL of methanol followed by 3mL of ultrapure water
prior extraction. The spiked samples were passed through SPE car-
tridges at a flow rate of ˜1mL/min, catridges were dried under vacuum
for ˜5min, and stored at -20 °C for a week until elution. Cartridges were
allowed to reach ambient temperature and then eluted with 4mL of
methanol followed by 3mL of 5% ammonia in methanol. The extracts
were combined and concentrated to ˜250 μL under a gentle stream of
nitrogen at ambient temperature. The concentrate was transferred
quantitatively to an amber silanized HPLC vial and the final volume
was adjusted to ˜1mL with methanol. SPM was freeze-dried for ˜6 h,
allowed to reach room temperature, spiked with the internal standard
mixture, vortexed with 6mL of methanol, and ultra-sonicated for
30min. SPM samples were then centrifuged at 4500 rpm for 5min and
the supernatant liquid was collected. The SPM samples were re-ex-
tracted with another 6mL of methanol and the extracts were combined.
Extracted samples were then concentrated to ˜250 μL under a gentle
stream of nitrogen, quantitatively (several methanol rinses) transferred
to amber silanized HPLC vials, and adjusted the final volume to ˜1mL
with methanol. All prepared samples were subjected to ultra-perfor-
mance liquid chromatography (UPLC) tandem mass spectrometry (MS/
MS) analysis of target drug residues (Supporting Info).
2.2. Isotope dilution liquid chromatography-tandem mass spectrometry
The prepared samples were analyzed for target drug residues using
UPLC (Agilent 1290 Infinity II LC System) coupled with Triple
Quadrupole mass spectrometer (Agilent 6460) (Santa Clara, CA). The
gradient flow of HPLC grade methanol and 0.1% aqueous solution of
formic acid were used to separate analytes using a Force Biphenyl
chromatographic column (100mm×2.1mm i.d.× 1.8 μm particle
size). Target analyte’s peak identification was based on the relative
retention time (± 0.05min) to their standard solution, two parent-to-
daughter ions transitions, and the ratio of the abundance of quantitative
to qualitative ions (± 20%) (Skees et al., 2018). The isotopic dilution
mass spectrometry method was applied where a known quantity of
deuterated isotopes of each target analyte (internal standard) is spiked
directly into the sample before sample preparation and analytes are
quantified based on the relative response factors of isotopic-labeled
internal standard and the corresponding analyte. This method allows
for accurate quantification by correcting for the loss of analytes during
the sample preparation and instrumental analysis process. The five-to-
ten-point calibration curves of each target analyte were prepared by
plotting the concentration-dependent response factor against the re-
sponse dependent concentration factor. The linear or quadratic (four
analytes) regression coefficients determined using Agilent MassHunter
Workstation for the Quantitative Analysis were r2 ≥0.99 for all ana-
lytes. The details of quality assurance and quality controls are provided
in supporting information.
2.3. Estimation of population
Three candidate hydrochemical markers: ammoniacal nitrogen
(NH4-N), total phosphorous, and biological oxygen demand (BOD) are













where CBi is the concentration of a hydrochemical marker (mg/L)
(Table S3), Fj is the wastewater inflow (L/d) for the jth day, and RBi is an
average per capita daily production of the ith hydrochemical marker
(NH4-N: 6900mg/d (Been et al., 2014); phosphorous: 1700mg/d (van
Nuijs et al., 2011); and BOD: 5900mg/d (van Nuijs et al., 2011)). The
estimated population using these markers varied considerably during
seven days of the sampling period (Fig. S1). Overall, NH4-N based po-
pulation (Table 1) was found more reliable (RSD: 18%, n=7) com-
pared to the total phosphorus (RSD: 21%, n=7) and BOD-based po-
pulations (RSD: 36%, n=7) in urban A; therefore, it was considered to
estimate the prevalence of substance uses in this study. Though more
accurate, NH4-N based population still subject to have uncertainty and
is accounted through uncertainty analysis discussed in Section 2.5.
2.4. Estimation of the consumption rate of drugs
The mass load and the consumption rate of target drugs were de-
termined using Eqs. (2) and (3) similar as described elsewhere (Foppe
et al., 2018; Subedi and Kannan, 2014; Skees et al., 2018).
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where mass load is the amount of individual illicit drugs introduced into
WWTP (mg/d), C is the total nanograms of analytes in 1 L of wastewater
influent and SPM combined (ng/L), F is the daily flow rate of waste-
water influent (L/d) over a 24 h period, and stability is a measure of
stability change (%) of analyte in wastewater up to 12 h (Table S1). SC
and SF are the standard errors associated with the estimated sample
mean concentration of drugs and the wastewater inflow, respectively.
Similarly, consumption rate of drugs was determined as the milligrams
of drugs per 1000 people, Ex is the percentage excretion rates (Table
S2),MWpar is the molar mass of parent drug, MWmet is the molar mass of
metabolite, Pop is an estimated population size based on NH4-N load in
the raw wastewater. The SML, SEx, SPop are the standard errors asso-
ciated with the estimated average mass load, reported excretion rates,
and the estimated population, respectively. The mass loadings and the
cosnumption rates of cocaine, heroin, methadone, and THC were de-
termined based on the residual levels of their stable metabolites in the
wastewater: benzoylecgonine, 6-acetyl morphine, EDDP, and THCA,
respectively. The mass loading and the consumption rate of all other
Table 1





Urban A 190,000 13.1 ± 1.2 189,335 ± 12,757
Urban B 150,000 14.1 ± 1.6 157,796 ± 20,187
Rural 20,000 9.82 ± 0.34 21,835 ± 1742
*provided by the WWTP operators; **average ± standard error.
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drugs were determined utilizing the residual concentrations of their
unchanged parent drugs in wastewater.
2.5. Uncertainty treatment using Monte Carlo simulation
All input variables used in the Eqs. (2) and (3) are measured with
the error or reported with inherent uncertainty. Consequently, esti-
mates from back-calculations subject to various uncertainties associated
with different variables or different steps involved or both. Ad-
ditionally, the formula used for determining mass loading and the
consumption rates are not a linear function of the individual parameters
used, and thus the errors associated with the estimates are not trackable
analytically. As the calculation became more complex, a more general
approach is needed to account uncertainties (Jones et al., 2014).
In this study, we implemented a Monte Carlo (MC) simulation to
account multiple sources of uncertainty associated with the individual
parameters involved in WBE estimations. The MC is a computing al-
gorithm to draw repeated random sampling from a given probability
distribution and offers powerful tools to model propagation of the un-
certainties. For implementing MC methods, all parameters involved in
the back-calculation (Eqs. (2) and (3)) are assumed to have a normal
distribution with an estimated value of the parameter as the mean and
associated standard error of the estimate to the standard deviation of
the distribution (see tables S1, S2, S3, and S4 for the sample mean and
associated standard error). For drugs with only one reported value for
stability and excretion rate, the same value was used in all MC samples
while performing back calculations. Individual values of the input
parameter are then randomly generated from the assumed normal
distribution, and the simulated values of the input parameters are later
used in the back calculations. The use of these repeated random sam-
ples of input parameter in the back calculations generate simulated
values for the variable of interest such as mass loading and the con-
sumption rates. The values obtained from the back calculations are used
to find the point estimates and confidence interval for the parameter
such as average mass loading and average per capita consumption rates.
Additionally, for comparing prevalence of the substance use in three
communities, mean difference (MD), as well as 95% confidence interval
for MDs, are constructed. A 95% confidence interval for a true para-
meter is interpreted as a range in which there is a 95% probability that
the true parameter lies. Two communities are considered significantly
different at the 5% significance level if a 95% confidence interval (CI)
for the MD does not contain zero.
3. Results and discussion
Seven residual illicit drugs and sixteen prescribed psychoactive
drugs were detected in 100% of the collected wastewater samples from
two WWTP in urban communities (Table S4). Benzoylecgonine, a co-
caine metabolite, dominates the illicit drug profile while anti-
depressants dominate the prescribe psychoactive drug levels in waste-
water.
3.1. Drug consumption in two adjoined urban communities
Urban communities include one of the most educated (> 43.6% of
people have at least college education) and lively (˜40% population
adults) cities in the country. The urban community A (urban A here-
inafter) in Eastern Kentucky comprises the central business district,
downtown, industrial, and the University area. Similarly, the adjoined
community B (urban B hereinafter) is a fast-growing suburban area.
Table 2 presents the mean consumption rate, MD of the consump-
tion rates and associated 95% CI. The mean per-capita consumption
rate of cocaine in the central business district (urban A: 3830mg/d/
1000 people) was found significantly higher (MD: 1980mg/d/1000
people) than in urban B (1850mg/d/1000 people) while the con-
sumption rate of other stimulants such as amphetamine,
methamphetamine, and methylphenidate was statistically equivalent.
(Table 2 and Fig. 1). Accounting several individual uncertainties in
WBE estimation, Lai et al. (2011) also reported several hundred milli-
grams of daily consumption of cocaine, methamphetamine, and MDMA
per 1000 people daily in a vibrant urban community (population
˜300,000–350,000) in South East Queensland, Australia (Lai et al.,
2011).
Similarly, among nine potentially abused opioids/narcotics, the
hydromorphone consumption in urban A (67mg/d/1000 people) was
found significantly higher (MD: 27mg/d/1000 people) than in urban B.
The buprenorphine was consumed most in both communities
(˜1600mg/d/1000 people) followed by oxycodone (˜500mg/d/1000
people) among the prescribed narcotics. In fact, the prescription doses
of buprenorphine and oxycodone in these communities were the
highest in Kentucky (Kentucky All Schedule Prescription Electronic
Reporting, 2018).
Recently, fentanyl overdose death rates (52% of total overdose
deaths) surpassed the heroin-related as well as the prescription opioid-
related deaths in Kentucky (Kentucky Injury Prevention and Research
Center, 2019). The fentanyl and heroin-related overdose deaths in
urban A and B were among the highest in the state (Kentucky Office of
Drug Control Policy, 2017). In this study, the prevalence of fentanyl and
heroin abuse were similar in both urban communities. Although the
prevalence of cocaine abuse and hydromorphone use was significantly
higher in the central business district, the consumption rate of pre-
scribed psychoactive drugs such as carbamazepine [1580 (MD: 835)
mg/d/1000 people] and temazepam [benzodiazepine of potential
abuse, 37 (MD: 21) mg/d/1000 people] were significantly higher in
urban B.
3.2. Prevalence of drug consumption between urban and rural communities
The median per-capita income of a rural community ($17,650) was
1.8 times lower than in urban A and B (United States Census Bureau,
2019). The estimated average population of rural, urban A, and urban B
communities were 21,835 ± 1742, 189,335 ± 12,757, and
157,796 ± 20,187, respectively, based on ammoniacal nitrogen load
in raw wastewater for a week (Table 1). Our research group reported
the consumption rates of several drugs from a rural community in
western Kentucky (Skees et al., 2018). The reported consumption rate
of drugs in a rural community in western Kentucky, after incorporating
the potential uncertainties in WB-epidemiological estimation, is hereby
compared to that found at two urban communities.
The prevalence of cocaine consumption was significantly higher in
urban communities compared to a rural community whereas the con-
sumption rates of amphetamine and methylphenidate are significantly
higher in the rural community (Table 2, Fig. 2). One-day equivalent
dose of cocaine costs approximately $110 while the amphetamine/
methamphetamine cost $40 per day (Postigo et al., 2008; Department
of Consumer Protection, 2019; RehabCenter.net, 2019). In Australia, a
WBE study that involved WWTPs serving 40% of the continent’s po-
pulation found that the cocaine consumption in urban areas was higher
than rural areas by up to two orders of magnitude (Lai et al., 2016).
In contrast to the present study, the majority of recent WBE studies
have found that methamphetamine consumption is similar in both
urban and rural areas with no clear geographical pattern (Lai et al.,
2016; Du et al., 2015). Thomas et al. found an inverse relationship
between cocaine and methamphetamine prevalence in a study com-
paring 19 European cities, in which Finland, Norway, and the Czech
Republic had low rates of cocaine consumption but the highest rates of
methamphetamine use (Thomas et al., 2012). In the Midwest U.S.,
particularly western Kentucky, the clandestine methamphetamine la-
boratories are historically more prevalent (National Drug Intelligence
Center, 2019; United States Drug Enforcement Agency, 2019). There-
fore, the relative lower cost and accessibility of methamphetamine/
amphetamine can have resulted in a higher prevalence in the rural
T.L. Croft, et al. Journal of Hazardous Materials 384 (2020) 121306
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Table 2
Consumption rate of drugs in urban A, urban B, and a rural community in Kentucky, U.S. The values in parenthesis represent the 95% confidence interval.




Urban A Urban B Rural Urban A - Urban B Urban A - Rural Urban B - Rural
Stimulants
Cocaine (CCN)* 3830 (2850, 5060) 1850 (1170, 2780) 864 (471, 1440) 1980 (785, 3250) 2960 (1920, 4200) 984 (149, 1970)
Cocaine** 2790 (2040, 3710) 1180 (748, 1760) 363 (199, 603) 1610 (698, 2600) 2430 (1650, 3350) 816 (332, 1430)
Amphetamine (AMP) 400 (279, 556) 344 (208, 535) 738 (446, 1100) 344 (208, 535) −338 (-677, -43) −393 (-748, -78)
Methamphetamine (MAPT) 1030 (721, 1400) 1160 (694, 1790) 1660 (985, 2460) 1160 (694, 1790) −629 (-1430, 81) −276 (-1260, 581)
Methylphenidate (MPD) 284 (185, 398) 290 (198, 415) 605 (372, 885) −6 (-163, 142) −321 (-616, -62) −315 (-611, -50)
Opioids/Narcotics
Heroin* (HER) 1620 (961, 2700) 1810 (600, 3610) n/a −187 (-1730, 1130) n/a n/a
Morphine (MPH) 312 (208, 452) 229 (140, 357) 99 (54, 167) 83 (-46, 214) 213 (107, 345) 130 (34, 254)
Methadone* (MTD) 106 (65, 178) 92 (53, 160) 1410 (708, 2600) 14 (-31, 60) −1300 (-2450,
-620)
−1317 (-2490, -635)
Methadone** 449 (289, 716) 428 (253, 716) NA 21 (-178, 204) NA NA
Codeine (CDN) 50 (31, 86) 52 (28, 96) 192 (87, 388) −2 (-32, 21) −142 (-320, -44) −140 (-319, -42)
Fentanyl (FNT) 169 (85, 391) 134 (54, 324) 31 (13, 72) 35 (-57, 150) 138 (66, 327) 103 (32, 267)
Oxycodone (OCD) 566 (272, 1060) 459 (232, 866) 465 (217, 919) 107 (-230, 474) 101 (-281, 488) −6 (-367, 325)
Hydrocodone (HCD) 166 (126, 213) 134 (93, 189) 507 (289, 820) 33 (-35, 95) −341 (-657, -118) −373 (-689, -149)
Hydromorphone (HMP) 67 (51, 87) 40 (28, 56) 142 (82, 226) 27 (4, 51) −75 (-161, -11) −102 (-187, -40)
Buprenorphine (BPN) 1700 (1220, 2260) 1480 (975, 2150) 3150 (1800, 5030) 219 (-568, 955) −1450 (-3370, -2) −1670 (-3600, -176)
Hallucinogens
MDMA 28 (19, 40) 21 (11, 36) n/a 7 (-10, 21) n/a n/a
MDEA 25* < LOQ n/a n/a n/a n/a





n/a 9400 (-35500-53200) n/a n/a
Antischizophrenics
Quetiapine (QTP) 31 (26, 36) 33 (21, 48) 31 (18, 49) −2 (-21, 14) 0 (-22,17) 2 (-22, 18)
Sedatives-Hypnotics-Anxiolytics
Lorazepam (LZP) 8 (5, 10) 12 (8, 17) 26 (16, 37) −4 (-11, 1) −14 (-29, -4) −14 (-27, -4)
Alprazolam (APZ) 66 (53, 81) 68 (49, 94) 30 (17, 50) −2 (-31, 23) 36 (13, 56) 38 (10, 68)
Diazepam (DZP) 3 (2, 5) < LOQ 4 (2, 4) n/a −1 (-3, 2) n/a
Oxazepam (OXZ) 3 (2, 5) 4 (2, 7) 40 (23, 63) −1 (-4, 2) −37 (-60, -20) −36 (-59, -19)
Temazepam (TMZ) 16 (10, 23) 37 (24, 55) 83 (48, 132) −21 (-40, -6) −67 (-116, -32) −46 (-96, -7)
Carbamazepine (CRB) 749 (567, 959) 1580 (1000, 2350) 615 (347, 1000) −835 (-1620, -217) 134 (-289, 479) 969 (279, 1780)
Antidepressants
Sertraline (SRT) 11700 (7960, 15100) 14300 (9020, 21400) 4030 (2180, 6730) −2700 (-11600, 4610) 7620 (2550, 12,150) 10300 (5230, 14000)
Fluoxetine (FLX) 581 (459, 724) 787 (547, 1110) 210 (115, 349) −206 (-547, 73) 371 (192, 545) 577 (304, 923)
Venlafaxine (VNF) 4750 (3470, 6240) 6230 (4200, 8960) 5450 (3150, 8720) −1480 (-4400, 1010) −705 (-4160, 2020) 775 (-3060, 4350)
Citalopram (CTP) 916 (536, 1600) 1080 (599, 1940) 1160 (565, 2250) −159 (-720, 285) −248 (-1060, 323) −89 (-909, 603)
*based on the concentration of a metabolite; **based on the concentration of residual parent drug; bolds values are significantly different (range of mean difference
did not include zero); < LOQ: below the limit of quantitation, n/a: non-applicable.
Fig. 1. The prevalence of select illicit and prescribed neuropsychiatric drugs in two adjoined urban communities. Cocaine* and Methadone* represent the con-
sumption rates determined based on the residual level of the parent cocaine and methadone, respectively, while Heroin* and THC* represent the consumption rates
determined based on the residual level of the metabolites 6-acetyl morphine and THCA, respectively. The prevalence of all other drugs were determined based on the
residual level of their parent drugs.
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community in western Kentucky. Amphetamine and methylphenidate,
schedule II stimulants, are the active ingredients of prescribed drugs
Adderall®, Concerta®, Ritalin®, etc. As the prescription rate of amphe-
tamine and methylphenidate drugs is higher in urban A and B com-
munities (Jones et al., 2014); a significantly higher consumption rate of
these drugs in the western rural community suggests additional sources
of amphetamine and methylphenidate. The overall consumption of
schedule II stimulants in Kentucky is predominant (> 2 folds higher)
among individuals age<34 compared to the individuals> 34 (Jones
et al., 2014), and ˜10% of the total population are current college
students in urban A and B communities while ˜40% of the total popu-
lation are current college students in the rural community. Therefore,
the difference in population profile in urban and rural communities can
also have contributed to a differential consumption rate of ampheta-
mine and methylphenidate.
The opioid overdose resulting>130 fatalities every day in the U.S.,
and the opioid-related overdose deaths in Kentucky is one of the highest
in the country (National Institute on Drug Abuse, 2019). In this study,
the prevalence of fentanyl and morphine consumptions in urban com-
munities were significantly higher than in a rural community while the
prevalence of prescribed opioids such as codeine, hydrocodone, hy-
dromorphone, and buprenorphine consumptions was significantly
higher in the rural community (Table 2, Fig. 2). This suggests that the
overall prevalence of opioid consumption in rural communities can be
equally or higher than in urban communities.
Among prescribed psychoactive drugs, alprazolam was found sig-
nificantly higher in urban communities while temazepam, oxazepam,
and lorazepam were found significantly higher in the rural community.
The consumption rate of carbamazepine in an urban B was significantly
higher [1584 (MD: 969) mg/d/1000 people] than in a rural commu-
nity. Similarly, the consumption of sertraline, a prescribed anti-
depressant, in urban communities was 2–3 folds higher than in the rural
community.
3.3. WBE-derived vs conventional estimates of the prevalence of substance
uses
The statewide controlled substance prescription monitoring system,
Kentucky All Schedule Prescription Electronic Reporting (KASPER),
reports a threshold analysis report based on the conventional estimate
of select schedule II through V controlled substance –dispensing in
Kentucky (Jones et al., 2014). Based on the reported prescription doses
per 1000 people in all 120 counties in the state including the study
areas and the typical daily doses (www.rxlist.com), the total amount of
prescribed drugs (milligrams/day) were determined and compared with
the WBE estimates in this study (Fig. 3). The population of urban
communities in this study represents ˜90% of the total population in a
county while the population of a rural community represents approxi-
mately two-third of the total population in a county.
The prevalence of alprazolam and oxycodone in urban communities
was ˜3 folds higher than the reported prescriptions-based KASPER es-
timations (Fig. 3); however, KASPER’s estimations in a rural community
are within 95% confidence interval of WBE estimation. It suggests the
potential abuse of alprazolam and oxycodone in urban communities.
Similarly, buprenorphine is 2–3 orders of magnitude higher prevalent
in urban and rural communities compared to KASPER’s estimation
suggests the potential abuse of buprenorphine in both communities.
Kentucky Injury Prevention and Research Center (KIPRC) issues the
county profiles on drug-related inpatient hospitalizations and emer-
gency department visits in Kentucky (Kentucky All Schedule
Prescription Electronic Reporting, 2018). Based on KIPRC’s report in
2018, the drug-related impatient hospitalization and emergency de-
partment visits by the dependent and nondependent abusers per 1000
people in urban and rural counties were calculated. The total hospital
visits by the hypnotic-sedative-anxiolytic abusers in urban communities
A and B (0.87/1000 people) were ˜2 folds higher than in a rural com-
munity, which is a very close agreement to WBE estimations for al-
prazolam in this study (Fig. 3). Similarly, hospital visits by the cocaine
abuser’s in urban communities were an order of magnitude higher than
in a rural community which is also supported by the significantly higher
consumption rate of cocaine in urban communities in this study.
However, KIPRC estimation of amphetamine abusers in both commu-
nities are similar (˜3 per 1000 people) despite a significantly higher
consumption rate of amphetamine in the rural community was found in
this study.
3.4. Need for the evidence-based prevalence of substance uses
As it has been demonstrated herein and several other studies, the
conventional approaches typically underestimate the actual prevalence
Fig. 2. The prevalence of select illicit and prescribed neuropsychiatric drugs in urban A and a rural community. Cocaine* and Methadone* represent the consumption
rates determined based on the residual level of the parent cocaine and methadone, respectively, while Heroin* and THC* represent the consumption rates determined
based on the residual level of the metabolites 6-acetyl morphine and THCA, respectively. The prevalence of all other drugs were determined based on the residual
level of their parent drugs.
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of substances use in communities. The European Monitoring Center for
Drugs and Drug Addiction (EMCDDA) established a cooperation with a
group of wastewater-based epidemiologists (Sewage Analysis Core
Group in Europe: SCORE) and monitoring wastewater currently from
70 European cities and complement with the WBE findings to combat
drug abuse problems (Sewage Analysis Core Group in Europe, 2018).
EMCDDA confirmed the overall recent surge in cocaine market in
European countries based on the targeted “trendspotter” study findings
such as elevated cocaine-related hospital admissions, deaths, and the
WBE findings (European Monitoring Center for Drugs and Drug
Addiction, 2019). Based on WBE findings, the Australian Criminal In-
telligence Commission recently reported that 9.6 tons of methamphe-
tamine, 4 tons of cocaine, 1.1 tons of MDMA and 700 kg of heroin were
consumed within 12 months accounting ˜$9.3 billion (Australian
Criminal Intelligence Commission (ACIC), 2019). Despite being con-
sidered one of the countries with the highest prevalence of substance
use, WBE researchers in the U.S. have encountered a number of hurdles
such as limited funding, access to the wastewater samples, so-called
“privacy” concerns, and a lack of public health authorities’ awareness
on applications of WBE findings (Subedi and Burgard, 2019). At a time
when drug use is on the rise, specifically for the opioid epidemic, a cost-
effective and semi-real time WBE approach for the comprehensive es-
timation of prevalence of substance use in rural as well as urban
communities would be invaluable to establish an early warning system
for public health biomarkers. Cost-effective and near-real-time WBE
findings can assist public health surveillance programs.
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